A phase 1/2 trial of perifosine in the treatment of non-small cell lung cancer.

Trial Profile

A phase 1/2 trial of perifosine in the treatment of non-small cell lung cancer.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Perifosine (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Sponsors AEterna Zentaris Inc
  • Most Recent Events

    • 25 Jan 2012 Status changed from suspended to completed as reported by ClinicalTrials.gov.
    • 25 Jan 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
    • 08 Jun 2011 Status changed from discontinued to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top